These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 7018522

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Amantadine and a fixed combination of carbidopa and levodopa in parkinsonism: a preliminary report.
    Savery F.
    Curr Ther Res Clin Exp; 1976 Mar; 19(3):337-8. PubMed ID: 817863
    [No Abstract] [Full Text] [Related]

  • 5. [Psychological changes in parkinsonian patients during L-DOPA, amantidine, and L-DOPA + IDC treatment (author's transl)].
    Puca FM, Megna GF, Masi G, Specchio LM.
    Riv Patol Nerv Ment; 1974 Oct; 95(5):676-84. PubMed ID: 4470268
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Modification of Parkinson tremor by budipine. A comparative study with amantadine].
    Iizuka J, Fischer R.
    Nervenarzt; 1986 Mar; 57(3):184-6. PubMed ID: 3515215
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Efficacy of amantadine sulfate as a infusion solution in the treatment of parkinsonian syndrome].
    Muschard F, Völler GW.
    Med Welt; 1973 Feb 02; 24(5):183-4. PubMed ID: 4617092
    [No Abstract] [Full Text] [Related]

  • 14. Treatment of Parkinson's Disease with levodopa and amantadine used as single drugs and in combined therapy.
    Callagham N, Mcllroy M, O'Connor M.
    Ir J Med Sci; 1974 Mar 02; 143(2):67-78. PubMed ID: 4617744
    [No Abstract] [Full Text] [Related]

  • 15. The L-dopa sparing effect of G 31,406 in the treatment of parkinson's disease.
    Couto B, Oliveira C, Mattos JP, Freitas MR.
    Neurol Neurocir Psiquiatr; 1976 Mar 02; 17(4):285-92. PubMed ID: 798128
    [Abstract] [Full Text] [Related]

  • 16. [Secondary effects of prolonged levodopa therapy in Parkinson's disease].
    Peiró Grasa A, Grau-Veciana JM.
    Med Clin (Barc); 1985 Jun 15; 85(3):88-91. PubMed ID: 4021630
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The effect of Dopaflex and Viregyt-K on gait and postural disturbances of operated and non-operated Parkinsonian patients.
    Boczán G, Borus F, Rózsa L.
    Ther Hung; 1975 Jun 15; 23(1):17-20. PubMed ID: 1105872
    [No Abstract] [Full Text] [Related]

  • 19. Long-term therapy of Parkinson's disease with amantadine, alone and combined with levodopa.
    Zeldowicz LR, Hubermann J.
    Can Med Assoc J; 1973 Oct 06; 109(7):588-93. PubMed ID: 4582563
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.